IT201700123899A1 - Uso del fenoldopam per il trattamento della sindrome emolitico uremica - Google Patents

Uso del fenoldopam per il trattamento della sindrome emolitico uremica

Info

Publication number
IT201700123899A1
IT201700123899A1 IT102017000123899A IT201700123899A IT201700123899A1 IT 201700123899 A1 IT201700123899 A1 IT 201700123899A1 IT 102017000123899 A IT102017000123899 A IT 102017000123899A IT 201700123899 A IT201700123899 A IT 201700123899A IT 201700123899 A1 IT201700123899 A1 IT 201700123899A1
Authority
IT
Italy
Prior art keywords
fenoldopam
treatment
hemolytic syndrome
uremic hemolytic
uremic
Prior art date
Application number
IT102017000123899A
Other languages
English (en)
Inventor
Gianluigi Ardissino
Original Assignee
Fond Irccs Ca Granda Ospedale Maggiore Policlinico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fond Irccs Ca Granda Ospedale Maggiore Policlinico filed Critical Fond Irccs Ca Granda Ospedale Maggiore Policlinico
Priority to IT102017000123899A priority Critical patent/IT201700123899A1/it
Priority to US16/760,407 priority patent/US20200345747A1/en
Priority to PCT/IB2018/058466 priority patent/WO2019087049A1/en
Priority to BR112020008673-8A priority patent/BR112020008673A2/pt
Priority to IL274287A priority patent/IL274287B2/en
Priority to EP18803786.5A priority patent/EP3703697B1/en
Priority to ES18803786T priority patent/ES2910972T3/es
Publication of IT201700123899A1 publication Critical patent/IT201700123899A1/it
Priority to US18/139,349 priority patent/US20230330098A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IT102017000123899A 2017-10-31 2017-10-31 Uso del fenoldopam per il trattamento della sindrome emolitico uremica IT201700123899A1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT102017000123899A IT201700123899A1 (it) 2017-10-31 2017-10-31 Uso del fenoldopam per il trattamento della sindrome emolitico uremica
US16/760,407 US20200345747A1 (en) 2017-10-31 2018-10-30 Use of fenoldopam for the treatment of hemolytic uremic syndrome
PCT/IB2018/058466 WO2019087049A1 (en) 2017-10-31 2018-10-30 Use of fenoldopam for the treatment of hemolytic uremic syndrome
BR112020008673-8A BR112020008673A2 (pt) 2017-10-31 2018-10-30 uso de fenoldopam para o tratamento da síndrome hemolítico-urêmica
IL274287A IL274287B2 (en) 2017-10-31 2018-10-30 Use of fenoldopam for the treatment of hemolytic syndrome of blood transfusion
EP18803786.5A EP3703697B1 (en) 2017-10-31 2018-10-30 Use of fenoldopam for the treatment of hemolytic uremic syndrome
ES18803786T ES2910972T3 (es) 2017-10-31 2018-10-30 Uso de fenoldopam para el tratamiento del síndrome urémico hemolítico
US18/139,349 US20230330098A1 (en) 2017-10-31 2023-04-25 Use of fenoldopam for the treatment of hemolytic uremic syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000123899A IT201700123899A1 (it) 2017-10-31 2017-10-31 Uso del fenoldopam per il trattamento della sindrome emolitico uremica

Publications (1)

Publication Number Publication Date
IT201700123899A1 true IT201700123899A1 (it) 2019-05-01

Family

ID=61257036

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000123899A IT201700123899A1 (it) 2017-10-31 2017-10-31 Uso del fenoldopam per il trattamento della sindrome emolitico uremica

Country Status (7)

Country Link
US (2) US20200345747A1 (it)
EP (1) EP3703697B1 (it)
BR (1) BR112020008673A2 (it)
ES (1) ES2910972T3 (it)
IL (1) IL274287B2 (it)
IT (1) IT201700123899A1 (it)
WO (1) WO2019087049A1 (it)

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ARDISSINO GIANLUIGI ET AL: "Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome: an update", PEDIATRIC NEPHROLOGY, SPRINGER VERLAG, BERLIN, DE, vol. 33, no. 3, 18 October 2017 (2017-10-18), pages 457 - 461, XP036417113, ISSN: 0931-041X, [retrieved on 20171018], DOI: 10.1007/S00467-017-3813-2 *
BUNCHMAN TIMOTHY E: "Treatment of acute kidney injury in children: from conservative management to renal replacement therapy.", NATURE CLINICAL PRACTICE. NEPHROLOGY SEP 2008, vol. 4, no. 9, September 2008 (2008-09-01), pages 510 - 514, XP002782103, ISSN: 1745-8331 *
JOHANNA SCHEIRING ET AL: "Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)", PEDIATRIC NEPHROLOGY ; JOURNAL OF THE INTERNATIONAL PEDIATRIC NEPHROLOGY ASSOCIATION, SPRINGER, BERLIN, DE, vol. 23, no. 10, 13 August 2008 (2008-08-13), pages 1749 - 1760, XP019632034, ISSN: 1432-198X *
MENNE J ET AL: "Treatment of typical hemolytic-uremic syndrome ; Knowledge gained from analyses of the 2011outbreak ; Therapie des typischen hämolytisch-urämischen Syndroms ; Erkenntnisse aus dem--Ausbruch 20", DER INTERNIST ; ORGAN DES BERUFSVERBANDES DEUTSCHER INTERNISTEN ORGAN DER DEUTSCHEN GESELLSCHAFT FÜR INNERE MEDIZIN, SPRINGER, BERLIN, DE, vol. 53, no. 12, 22 November 2012 (2012-11-22), pages 1420 - 1430, XP035146482, ISSN: 1432-1289, DOI: 10.1007/S00108-012-3107-5 *
WIJNSMA KIOA L ET AL: "Unusual severe case of hemolytic uremic syndrome due to Shiga toxin 2d-producingE. coliO80:H2", PEDIATRIC NEPHROLOGY, SPRINGER VERLAG, BERLIN, DE, vol. 32, no. 7, 25 March 2017 (2017-03-25), pages 1263 - 1268, XP036240886, ISSN: 0931-041X, [retrieved on 20170325], DOI: 10.1007/S00467-017-3642-3 *

Also Published As

Publication number Publication date
EP3703697B1 (en) 2022-01-19
ES2910972T3 (es) 2022-05-17
WO2019087049A1 (en) 2019-05-09
BR112020008673A2 (pt) 2020-10-27
IL274287A (en) 2020-06-30
US20200345747A1 (en) 2020-11-05
IL274287B2 (en) 2024-06-01
IL274287B1 (en) 2024-02-01
EP3703697A1 (en) 2020-09-09
US20230330098A1 (en) 2023-10-19

Similar Documents

Publication Publication Date Title
GB2548873B (en) Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
GB201621480D0 (en) Use of cannabinoids in the treatment of angelman syndrome
DK3474802T3 (da) Medicinsk forbinding
IL273495A (en) Treatment of fragile X syndrome with cannabidiol
EP3570940A4 (en) USE OF PRIDOPIDINE TO TREAT THE FRAGILE X SYNDROME
IL249402A0 (en) Aminoglycosides for the treatment of Rett's syndrome
IT201600105430U1 (it) Letto ribaltabile per persone con disabilità
IT201700043757A1 (it) Dispositivo per il trattamento della pelle
DK3700486T3 (da) Patientvendeapparat
FI11701U1 (fi) Säädettävä sänkyrakenne
IT201700069456A1 (it) Dispositivo indossabile particolarmente per il trattamento della sindrome del tunnel carpale.
IT201700086482A1 (it) Composizione per il trattamento della vaginosi batterica
EP3590563A4 (en) BLOOD PURIFICATION DEVICE
EP3527233C0 (en) HONEYCOMB STRUCTURE FOR MEDICAL USE
IT201700123899A1 (it) Uso del fenoldopam per il trattamento della sindrome emolitico uremica
ZA201904694B (en) Medical device for the treatment of hpv cutaneous infections
IT201700107088A1 (it) Dispositivo per il filtraggio del sangue
EP3622980A4 (en) BLOOD PURIFICATION DEVICE
EP3636295A4 (en) BLOOD PURIFICATION DEVICE
DK3639333T3 (da) Overfladebehandlingsindretning med ekspansionselektrodearrangement
CL2015003211A1 (es) Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio.
ES1189085Y (es) Dispositivo para el tratamiento del sindrome de piernas inquietas
ES1200885Y (es) Dispositivo para el tratamiento del síndrome de predislocación metatarsofalángico
IT201900025414A1 (it) Composto per il trattamento della sindrome emolitico uremica
CL2018001871A1 (es) Uso de inhibidores de la actividad o función de pi3k para el tratamiento del síndrome de sjögren primario